Innate Pharma (IPHA) Total Non-Current Liabilities (2017 - 2026)
Innate Pharma's Total Non-Current Liabilities was $49.26 million in the quarter ended Jun 30, 2026, down 25.4% from $66.07 million a year earlier.
Powered by 
Analysis
Innate Pharma (IPHA) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends
As of Dec 31, 2025, Total Non-Current Liabilities at Innate Pharma came in at $53.98 million, down 28.0% from the prior year.
- Total Non-Current Liabilities has now declined for three consecutive years, with a five-year compound annual growth rate of -14.9% (years ended Dec 2020 to Dec 2025).
- In earlier years, Total Non-Current Liabilities was $74.94 million in the year ended Dec 31, 2024 (-17.2%), $90.49 million in the year ended Dec 31, 2023 (-17.3%), $109.41 million in the year ended Dec 31, 2022 (+19.3%) and $91.71 million in the year ended Dec 31, 2021 (-24.2%).
- The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Non-Current Liabilities since the quarter ended Jun 30, 2020.
- The best year-over-year quarter for Total Non-Current Liabilities over five years was the quarter ended Jun 30, 2023 (growth of 16.7%); the worst was the quarter ended Dec 31, 2021 (a decline of 27.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Innate Pharma | 159.32 Mn | 159.32 Mn | - | 49.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 49.26 Mn |
| Dec 31, 2025 | 55.61 Mn |
| Jun 30, 2025 | 66.07 Mn |
| Dec 31, 2024 | 73.99 Mn |
| Jun 30, 2024 | 90.97 Mn |
| Dec 31, 2023 | 90.00 Mn |
| Jun 30, 2023 | 112.72 Mn |
| Dec 31, 2022 | 105.91 Mn |
| Jun 30, 2022 | 96.61 Mn |
| Dec 31, 2021 | 91.71 Mn |
| Jun 30, 2021 | 108.43 Mn |
| Dec 31, 2020 | 126.33 Mn |
| Jun 30, 2020 | 42.96 Mn |
| Dec 31, 2019 | 68.76 Mn |
| Dec 31, 2018 | 99.57 Mn |
| Dec 31, 2017 | 112.04 Mn |
API Access
Innate Pharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IPHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "IPHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=IPHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();